首页> 美国卫生研究院文献>Healthcare Informatics Research >Biobanks as a Treasury for Precision Medicine
【2h】

Biobanks as a Treasury for Precision Medicine

机译:Biobanks作为精密药物的财宝

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Biobanks, as a bridge between clinical medicine and research, are essential systems to support advanced medical research, such as precision medicine. A biobank consists of an organized form of storage for biomaterial resources and the corresponding data. Advanced biotechnologies, computational tools, and large-scale databases to explain individual variability are needed to achieve precision medicine for disease prevention and treatment [1,2]. Biological samples and data such as demographic, genetic, clinical, and environmental information in biobanks must be protected for donors’ privacy and security with anonymization and identification procedures [1]. An international standard regarding these issues is provided by the EU Data Protection Directive [1]. Contemporary biobanks also have the important tasks of applying new technologies in biology and IT/ICT (information technology/information and communications technology) systems, implementing a standard coding system for biomaterials (such as the Standard PREanalytical Coding [SPREC] for biospecimens), and resolving ethical and legal issues.
机译:生物样本库,临床医学和研究之间的桥梁,是支持先进的医学研究关键系统,如精密药。生物库包括用于存储生物材料资源和相应的数据的有组织的形式的。先进的生物技术,计算工具,以及大型数据库来解释个体差异,需要实现精准医学对疾病的预防和治疗[1,2]。生物样品和数据,诸如在生物库的人口统计,遗传,临床和环境信息必须被保护为捐助者的隐私和安全与匿名和识别程序[1]。关于这些问题的国际标准是由欧盟数据保护指令[1]提供。现代生物银行也有生物学应用新技术的重要任务和IT / ICT(信息技术/信息和通信技术)系统,实现生物材料(如标准分析前编码[SPREC]用于生物标本)的标准编码体系,解决的伦理和法律问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号